Unbiased AI-powered news
1 stories related to this topic, newest first.
Substrate placeholder — needs reviewAvalyn Pharma, a biopharmaceutical company focused on inhaled therapies for respiratory diseases, has filed for an initial public offering in the United States. The filing aims to raise capital for advancing its pipeline of treatments targeting conditions such as pulmonary fibros…